Avrupa Birliği -
Danca -
EMA (European Medicines Agency)
xenpozyme
sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - andre alimentary tract and metabolism produkter, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.
Avrupa Birliği -
Danca -
EMA (European Medicines Agency)
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - glycogen opbevaring sygdom type ii - andre alimentary tract and metabolism produkter, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).
Avrupa Birliği -
Danca -
EMA (European Medicines Agency)
elfabrio
chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry disease - andre alimentary tract and metabolism produkter, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).
Avrupa Birliği -
Danca -
EMA (European Medicines Agency)
agenerase
glaxo group ltd. - amprenavir - hiv infektioner - antivirale midler til systemisk anvendelse - agenerase, i kombination med andre antiretrovirale midler, er indiceret til behandling af proteasehæmmere (pi), der har oplevet hiv-1-inficerede voksne og børn over 4 år. agenerase kapsler bør normalt administreres med lavdosis ritonavir som en farmakokinetisk forstærker af amprenavir (se afsnit 4. 2 og 4. valget af amprenavir bør baseres på individuel test af viral resistens og behandlingshistorie hos patienter (se afsnit 5. gavn af agenerase forstærket med ritonavir er ikke blevet vist i pi nave patienter (se afsnit 5.
Danimarka -
Danca -
Lægemiddelstyrelsen (Danish Medicines Agency)
betolo appelsin 2+0,60+1,20 mg sugetabletter
mundipharma a/s - amylmetacresol, dichlorbenzylalkohol, lidocainhydrochloridmonohydrat - sugetabletter - 2+0,60+1,20 mg
Danimarka -
Danca -
Lægemiddelstyrelsen (Danish Medicines Agency)
betolo mint 2+0,60+1,20 mg sugetabletter
mundipharma a/s - amylmetacresol, dichlorbenzylalkohol, lidocainhydrochloridmonohydrat - sugetabletter - 2+0,60+1,20 mg
Avrupa Birliği -
Danca -
EMA (European Medicines Agency)
rivastigmine 3m health care ltd
3m health care limited - rivastigmin - alzheimers sygdom - psychoanaleptics, , anticholinesterases - symptomatisk behandling af mild til moderat alvorlig alzheimers demens.
Avrupa Birliği -
Danca -
EMA (European Medicines Agency)
nimvastid
krka, d.d., novo mesto - rivastigmin - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatisk behandling af mild til moderat alvorlig alzheimers demens. symptomatisk behandling af mild til moderat svær demens hos patienter med idiopatisk parkinsons sygdom.